Research identifies LSP1 as a prognostic biomarker linked to apoptosis in acute myeloid leukemia, suggesting therapeutic implications.
This study revealed that LSP1 plays a crucial role in the progression of AML, indicating its potential as a prognostic biomarker and therapeutic target.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: